ModivCare Inc. Faces Delisting Concerns

Modivcare Inc 8-K Filing Summary
FieldDetail
CompanyModivcare Inc
Form Type8-K
Filed DateAug 22, 2025
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.001
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory

TL;DR

ModivCare might be delisted - check exchange rules.

AI Summary

ModivCare Inc. filed an 8-K on August 22, 2025, reporting events as of August 20, 2025. The filing primarily concerns a notice of delisting or failure to meet continued listing standards, a Regulation FD disclosure, and financial statements/exhibits. ModivCare Inc. was formerly known as Providence Service Corp.

Why It Matters

This filing indicates potential issues with ModivCare Inc.'s compliance with stock exchange listing rules, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: medium — The filing explicitly mentions a notice of delisting or failure to satisfy continued listing rules, indicating a significant risk to the company's public trading status.

Key Players & Entities

  • ModivCare Inc. (company) — Registrant
  • Providence Service Corp (company) — Former company name
  • August 20, 2025 (date) — Date of earliest event reported
  • August 22, 2025 (date) — Filing date

FAQ

What specific listing rule has ModivCare Inc. failed to satisfy?

The filing does not specify the exact listing rule that has been violated, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

What are the potential consequences of failing to meet continued listing standards?

Failure to meet continued listing standards can lead to the delisting of the company's securities from the stock exchange, which could negatively impact liquidity and investor confidence.

When was ModivCare Inc. formerly known as Providence Service Corp?

The date of the name change from Providence Service Corp to ModivCare Inc. was February 26, 2003.

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a notice of delisting or failure to satisfy a continued listing rule or standard, along with Regulation FD disclosures and financial statements/exhibits.

What is ModivCare Inc.'s principal executive office address?

ModivCare Inc.'s principal executive offices are located at 6900 E. Layton Avenue, 12th Floor, Denver, Colorado 80237.

Filing Stats: 1,345 words · 5 min read · ~4 pages · Grade level 13.8 · Accepted 2025-08-22 17:07:37

Key Financial Figures

  • $0.001 — nge on which registered Common Stock , $0.001 par value per share MODV The NASDAQ

Filing Documents

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 21, 2025, ModivCare Inc. (the "Company") received a notification letter (the "Delisting Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that Nasdaq had determined to commence proceedings to delist the Company's common stock, $0.001 par value per share (the "Common Stock"), from Nasdaq. Nasdaq reached its decision that the Company is no longer suitable for listing pursuant to Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company's commencement of voluntary proceedings under Chapter 11 of the United States Bankruptcy Code on August 20, 2025. In addition, on August 20, 2025, the Company received a notification letter (the "Delinquency Notice") from Nasdaq notifying the Company that, because the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2025, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the Securities and Exchange Commission (the "SEC"). Nasdaq informed the Company that the Common Stock would be suspended at the opening of business on August 28, 2025. The Company does not intend to appeal Nasdaq's decision to delist their Common Stock and it is expected that Nasdaq will file a Form 25-NSE with the SEC, which would remove the Company's common stock from listing and registration on Nasdaq. The Company anticipates that, upon the delisting from Nasdaq, the Common Stock will be quoted on the OTC Pink Market. The Company, however, can provide no assurance that the Common Stock will commence or continue to trade on this market.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On August 22, 2025, the Company issued a press release announcing the information described in Item 3.01 of this Current Report on Form 8-K (this "Current Report"). A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference. The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing. Additional Information on the Chapter 11 Cases Additional information about the Chapter 11 Cases, including access to Bankruptcy Court documents, is available online at https://www.veritaglobal.net/ModivCare, a website administered by Kurtzman Carson Consultants, LLC d/b/a Verita Global, a third-party bankruptcy claims and noticing agent. The information on this website is not incorporated by reference into, and does not constitute part of, this Current Report. Cautionary Note Regarding the Company ' s Securities The Company cautions that trading in the Company's securities during the pendency of the Chapter 11 Cases is highly speculative and poses substantial risks. Trading prices for the Company's securities may bear little or no relationship to the actual recovery, if any, by holders of the Company's securities in the Chapter 11 Cases. Cautionary Note Regarding Forward-Looking Statements Certain statements contained in this Current Report on Form 8-K (the "Report") constitute "forward-looking statements" within the meaning of the P

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ModivCare Inc. Date: August 22, 2025 By: /s/ Faisal Khan Name: Faisal Khan Title: Senior Vice President, General Counsel and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.